Care-seeking behavior associated with 'upper-GI symptoms'September 09, 2009Patients with upper gastrointestinal (GI) complaints visit their general practitioner (GP) more often than patients with other conditions. Researchers writing in the open access journal BMC Family Practice found that people with dyspepsia, heartburn, epigastric discomfort and other upper-abdominal complaints had almost twice as many GP contacts, which were ultimately associated with problems in all organ systems. These patients were twice as frequently referred to specialist care and received twice as many prescriptions. Henk van Weert led a team of researchers from the University of Amsterdam who set out to investigate the connection between psychological conditions and upper-GI symptoms. He said, "Traditionally, psychological factors were held responsible for upper-GI symptoms. With the identification of Helicobacter pylori the etiological paradigm changed dramatically, but eradication therapy has proved to be of only limited value in functional dyspepsia. We aimed to investigate whether psychological and social problems are more frequent in patients with upper GI symptoms". The researchers found that the prevalence of upper-GI symptoms was actually associated with a broader pattern of illness-related health care use - GI patients' increased health care demands were not restricted to psychosocial problems, but comprised all organ systems. According to van Weert, "Patients with upper-GI symptoms visited their GP twice as often and received up to double the number of prescriptions as control patients. We demonstrated that not psychological and social co-morbidity, but high contact frequency in general is most strongly associated with upper-GI symptoms". Speculating as to the reason for the increased care-seeking among people with upper-GI symptoms, van Weert said, "Patients who consult their GP frequently because of their coping style and attentiveness to physical symptoms may just have a high chance to be diagnosed in any health domain, including the psychosocial. In other words, upper GI symptoms and psychosocial complaints may both be manifestations of increased health care demands and not etiologically related". BioMed Central |
|||||||||||||||||||||
| Related Gastrointestinal Current Events and Gastrointestinal News Articles Asthma a significant risk factor for complications in children with H1N1 A new study on pediatric H1N1 influenza admissions has found that asthma is a significant risk factor for severe disease in children with pandemic H1N1 compared with the seasonal flu. Engineer designs micro-endoscope to seek out early signs of cancer Traditional endoscopes provide a peek inside patients' bodies. Now, a University of Florida engineering researcher is designing ones capable of a full inspection. Unknowlingly consuming endangered tuna While most of us would never willingly consume a highly endangered species, doing so might be as easy as plucking sushi from a bento box. Largest gene study of childhood IBD identifies 5 new genes In the largest, most comprehensive genetic analysis of childhood-onset inflammatory bowel disease (IBD), an international research team has identified five new gene regions, including one involved in a biological pathway that helps drive the painful inflammation of the digestive tract that characterizes the disease. African-Americans with colorectal cancer have poorer outcomes, lower survival rates New research published in the November issue of the Journal of the American College of Surgeons shows that African-American patients with colorectal cancer are more likely to be diagnosed with advanced disease and are less likely to undergo surgical procedures compared with Caucasians, suggesting that improvements in screening and rates of operation may reduce differences in colorectal cancer outcomes for African-Americans. Aileron collaborates study in Nature: Stapled peptides inhibit Notch1 transcription factor This research validates the potential for Stapled Peptides to modulate key intracellular biological targets, such as transcription factors, that have not been addressable with current small molecule or biologic drug modalities. Researchers 'notch' a victory toward new kind of cancer drug Scientists have devised an innovative way to disarm a key protein considered to be "undruggable," meaning that all previous efforts to develop a drug against it have failed. Curry-cure? Spicing up the effectiveness of a potential disease-fighter Scientists are reporting development of a nano-size capsule that boosts the body's uptake of curcumin, an ingredient in yellow curry now being evaluated in clinical trials for treatment of several diseases. Gastroenterology/hepatology societies release report evaluating fellowship training curriculum Due to the increasing complexities of treating digestive diseases, allowing gastroenterological (GI) trainee physicians the opportunity to develop enhanced abilities and experiences in specific disease areas or procedures will be a great benefit to patients, according to a "Report of the Multisociety Task Force on GI Training." Progress made on group B streptococcus vaccine Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have completed a Phase II clinical study that indicates a vaccine to prevent Group B Streptococcus (GBS) infection is possible. More Gastrointestinal Current Events and Gastrointestinal News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||